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68Objective: We sought to identify suitable patients for the Ross operation.
Methods: A cohort of 212 patients (mean age, 34 9 years; 66%men; 82%with congenital aortic valve disease)
underwent the Ross operation and was prospectively followed with clinical evaluations and echocardiographic
analysis for 3.1 to 18 years (mean, 10.1  4.2 years). In addition to longitudinal outcomes determined by means
of Kaplan–Meier analysis, Cox regression analysis was used to identify predictors of valve failure.
Results: There were 1 operative and 4 late deaths, none of which were valve related. Survival at 15 years was
96.6%  1.5% and similar to that seen in the general population matched for age and sex. There were 20 reop-
erations: 13 in the pulmonary autograft, 3 in the pulmonary homograft, and 4 others. Freedom from reoperation in
the pulmonary autograft at 15 years was 92.1% 2.3%. Aortic insufficiency was the only independent predictor
of reoperation. Freedom from moderate or severe aortic insufficiency at 15 years was 89.7%, and greater than
mild aortic insufficiency was 63.2%. Male sex, aortic/pulmonary annular mismatch, aortic annulus of 27 mm
or larger, and preoperative aortic insufficiency were associated with higher risk of late aortic insufficiency by
means of log-rank analysis. Cox regression analysis identified male sex as the only independent predictor of
postoperative aortic insufficiency. Freedom from moderate or severe pulmonary insufficiency, peak gradient
of 40 mm Hg or greater, or both at 15 years was 70.8%  6.8%, and event-free survival was 81%  3.7%.
Conclusions: The Ross operation provided suboptimal results in male patients with aortic insufficiency. The best
outcomes were in female patients, those with aortic stenosis, and those with an aortic annulus of less than 27 mm
in diameter. (J Thorac Cardiovasc Surg 2010;139:68-75)The enthusiasm for the Ross operation began to fade when
surgeons recognized its fallibility early on in this millen-
nium.1-3 Dilation of the neoaortic root was thought to be
the principal cause of aortic insufficiency (AI) and valve fail-
ure.1-3 Because dilation is less likely to occur when subcoro-
nary implantation or aortic root inclusion techniques are
used,1 one would expect better long-term outcomes with
these approaches than with the technique of aortic root
replacement, but a recent study suggests that the develop-
ment of late AI caused by degeneration of the pulmonary
cusps remains a problem regardless of the technique of
implantation.4 Degenerative changes in the pulmonary root
are commonly seen in patients with bicuspid aortic valve
disease, which is the most common indication for the Ross
operation in North America.5 It remains unknown whether
these arterial wall changes might also affect the pulmonary
cusps. For all these reasons, we do not know which patients,
if any, would benefit from the Ross operation. This study
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The Journal of Thoracic and Cardiovascular Surgeassociated with the development of AI and reoperations after
the Ross operation.
MATERIALS AND METHODS
From 1990 to 2004, 212 consecutive patients underwent Ross operations
performed by 1 surgeon. Table 1 shows the clinical profile of all patients.
Operative Techniques
The diameters of the aortic annulus and sinotubular junction were
measured with metric sizers after excision of the diseased aortic valve.
The sinotubular junction of the pulmonary autograft was also measured,
and the diameter of the pulmonary annulus was estimated to be 10% larger
than the diameter of the sinotubular junction. If the diameter of the aortic
annulus was more than 2 mm larger than the estimated diameter of the
pulmonary annulus, the aortic annulus was surgically reduced before the
pulmonary autograft was sutured in the left ventricular outflow tract.
Similarly, if the aortic sinotubular junction was larger than the pulmonary
sinotubular junction by more than 2 mm, the aortic sinotubular junction
and ascending aorta were plicated before the autograft was sutured within
the aortic root or to the ascending aorta.6 The mean diameter of the aortic
annulus was 26.75  3.69 mm (range, 17–40 mm; 28.5  2.9 mm for
men and 23.7  3.0 mm for women). The mean diameter of the pulmonary
sinotubular junction was 22.90  1.91 mm (range, 18–27 mm; 23.6  1.5
mm for men and 21.7 3.0 mm for women). In addition, the aortic annulus
diameters were transformed to z values by using previously published
methods.7 Reduction of the aortic annulus was performed in 90 patients,
and reduction of the sinotubular junction was performed in 60 patients.
The valve lesion in patients who had annular reduction was stenosis in
24, insufficiency in 54, and mixed in 12.
The pulmonary autograft was secured in the aortic position by using
a modified subcoronary implantation or aortic root inclusion in 104 patients
and as a freestanding neoaortic root in 108 patients. The decision to use an
inclusion technique (subcoronary or root inclusion) or root replacement was
largely dependent on the pathology of the aortic root, the sizes of the rootry c January 2010
TABLE 1. Clinical profile of patients
No. of patients 212
Age (mean  SD), y 34.6  9.4
Range 16–63
Sex
Male 140 (66)
Female 72 (34)
Associated diseases
Diabetes 2 (0.9)
Hypertension 29 (13.6)
Hypercholesterolemia 20 (9.4)
Chronic obstructive
pulmonary disease
5 (2.3)
Previous TIA/stroke 8 (3.7)
NYHA functional class
I 41 (19.3)
II 135 (63.6)
III 26 (12.2)
IV 10 (4.7)
Infective endocarditis
Healed 13 (6.1)
Active 2 (0.9)
Previous cardiac surgery
Aortic valve repair 18 (8.5)
Aortic valve replacement 12 (5.6)
Mitral valve repair 1
Left ventricular ejection fraction
>54% 127 (60)
40%–54% 67 (32)
<40% 18 (9)
Mitral regurgitation 3 (1.4)
Aortic valve disease
Stenosis 107 (50.4)
Insufficiency 77 (36.3)
Mixed lesion 28 (13.2)
Aortic valve pathology
Bicuspid 152 (71.7)
Other congenital 22 (10.3)
Prosthetic dysfunction 10 (4.)
Tricuspid calcific 3 (1.4)
Rheumatic 6 (2.8)
Miscellaneous 19 (9.0)
Body surface area (mean  SD), m2
Men 1.97  0.17
Women 1.70  0.20
Percentages are shown in parentheses. SD, Standard deviation; TIA, transient ischemic
attack; NYHA, New York Heart Association.
Abbreviations and Acronyms
AI ¼ aortic insufficiency
CI ¼ confidence interval
HR ¼ hazard ratio
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patients with a small aortic root, previous aortic valve surgery, or an anom-
alous right coronary artery orifice had mostly aortic root replacement,
whereas those with normal or dilated aortic roots had inclusion techniques.
The noncoronary aortic sinus was always opened down to the level of the
annulus when inclusion techniques were used to facilitate exposure. Recon-
struction of the right side of the heart was performed with a pulmonary
homograft in all patients except the first one of this series, who had an aor-
tic valve homograft. In addition to the Ross operation, 25 patients had re-
placement of the ascending aorta, 4 patients had mitral valve repair, and 3
patients had coronary artery bypass because of suspected intraoperative is-
chemia.
Follow-up
The referring cardiologists followed the patients and provided us with
annual clinical and echocardiographic data and a tape or CD with the
most recent images obtained, which were reviewed by an experienced
echocardiographer in our institution (AW). The clinical follow-up was
complete and closed on September 30, 2008. It extended from 3.1 to 18
years (mean, 10.1 4.2 years). Patients had 724 echocardiographic studies
during the follow-up, but 8 patients had only 1 postoperative echocardio-
graphic study; 199 had a study during the last 2 years of follow-up that
was reviewed by one of us (AW). These postoperative studies were
performed at a mean 9.5  3.6 years (range, 0.1–17.7 years) and closed
on February 20, 2009. AI was graded according to the guidelines of the
American Society of Echocardiography.7
Statistical Analysis
All statistical analyses were conducted with SAS (version 9.1) software
for windows (SAS Institute, Inc, Cary, NC). Categorical variables were an-
alyzed by using c2 analyses or the Fisher’s exact test and were expressed as
percentages. All continuous variables were expressed as means  standard
deviations, and means were compared with the Student t test or Wilcoxon
rank test. The Kaplan–Meier method was used to compare survival and free-
dom from morbid events. Age- and sex-matched Ontario general population
survival estimates were obtained from the Life Table Template V1.2, a down-
loadable Excel spreadsheet available at http://www.healthinformation.on.
ca. Cox regression methods were used to identify independent
multivariable predictors of reoperation and AI and expressed as hazard
ratios (HRs) and 95% confidence intervals (CIs). The following variables
were tested for their independent value as predictive of reoperation and
development of AI: sex, age, functional class, preoperative aortic valve
lesion, aortic valve pathology, pulmonary autograft implantation
technique, aortic annulus diameter index, aortic annulus area index,
surgical reduction of the aortic annulus, surgical reduction of the
sinotubular junction, and replacement of the ascending aorta.RESULTS
Patients’ Survival
There were 1 operative and 4 late deaths. The operative
death was due to a perioperative myocardial infarction,
and the late deaths were sudden in 1 patient and not cardio-
vascular system related in 3 patients. Patients’ survival atThe Journal of Thoracic and C15 years was 96.6%  1.5%, and that of the general
population matched for age and sex was 97.5%, as shown
in Figure 1.Thromboembolic Complications
One patient had a transient ischemic attack 69 months
postoperatively, and 2 had a stroke with complete recovery
at 1 and 13 months postoperatively, respectively. The free-
dom from this complication at 15 years was 98.4% 0.8%.ardiovascular Surgery c Volume 139, Number 1 69
FIGURE 1. Survival after the Ross operation compared with that of the
population in general matched for age and sex.
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Three patients had infective endocarditis of the pulmo-
nary homograft at 7.4, 8.5, and 10.1 years postoperatively,
respectively. Two were successfully treated with antibiotics
alone, and 1 underwent surgical intervention. The patient
who underwent surgical intervention also had moderate AI
caused by degenerative changes of the pulmonary autograft
cusps and underwent successful aortic and pulmonary valve
replacement. The freedom from infective endocarditis at
15 years was 97.5%  1.4%.
Hemorrhagic Complications
There was no late major hemorrhagic event, but only 1
patient was taking warfarin sodium.
Reoperations
Thirteen patients required reoperation on the pulmonary
autograft: 1 soon after the initial operation because of AITABLE 2. Freedom from reoperation on the pulmonary autograft
5 y
Operative technique
Subcoronary/inclusion 96.3  1.8 (98)
Root replacement 96.9  1.7 (86)
Aortic/pulmonary annulus
No mismatch 98.2  1.2 (98)
Mismatch 94.6  2.3 (85)
Aortic annulus diameter
<27 mm 100 (80)
27 mm 94.0  2.1 (104) 8
Aortic valve lesion
Stenosis 99.0  0.9 (93)
Insufficiency 92.1  3.1 (65)
Mixed 100 (26)
Sex
Female 100 (61)
Male 94.8  1.8 (140)
All values are shown in percentages. P values were determined by using the log-rank test.
70 The Journal of Thoracic and Cardiovascular Surgecaused by a technical error (treated with aortic root
replacement), 9 for late AI caused by degeneration of
the cusps of the pulmonary autograft (all 9 treated with
aortic valve replacement), 1 for AI caused by dilation of
the ascending aorta and sinotubular junction (treated
with repair of 1-cusp prolapse and supracoronary replace-
ment of the ascending aorta), and 2 for a false aneurysm of
the pulmonary autograft/aortic annulus anastomosis (both
were repaired). All patients survived reoperation. Freedom
from reoperation on the pulmonary autograft at 15 years
was 92.1%  2.3%. Table 2 shows the Kaplan–Meier
estimates of freedom from reoperation on the pulmonary
autograft in various subgroups of patients. Cox regression
analysis identified preoperative AI (HR, 5.4; 95% CI,
1.2–24; P ¼ .03) as the only independent predictor of
reoperation on the pulmonary autograft.
Seven patients required other operations: 1 had replace-
ment of the ascending aorta for aneurysm with normally
functioning pulmonary autograft; 2 had pulmonary valve
replacement and 1 had transcatheter implantation of
a bioprosthetic valve in the failed pulmonary valve homo-
graft; and 3 had coronary artery bypass surgery. Thus 20
patients had reoperation or reintervention during the fol-
low-up period. Freedom from any reoperation or transcath-
eter valve implantation at 15 years was 85.2%  3.5%,
and freedom from reoperation on the pulmonary homograft,
including transcatheter valve implantation, was 97.3% 
1.6%. Figure 2 shows freedom from reoperations. Table 2
shows freedom from reoperation on the pulmonary autograft
in various subgroups of patients.Pathology of Explanted Pulmonary Autograft Valve
Ten valves were explanted: 1 was normal, and 9 had gross
evidence of degenerative changes with thinning and10 y 15 y P value
92.1  3.3 (34) 92.1  3.3 (10)
94.1  2.5 (62) 92.4  3.0 (4) .82
98.2  1.2 (44) 98.2  1.2 (6)
88.5  3.6 (52) 86.5  4.0 (8) .01
100 (43) 100 (3)
8.7  3.29 (53) 86.8  3.7 (11) .003
97.4  1.9 (47) 97.4  1.9 (3)
87.5  4.2 (34) 84.3  5.2 (10)
3.7  6.0 (15) 93.7  6.0 (1) .01
100 (35) 100 (7)
90.0  2.9 (61) 88.1  3.4 (7) .03
Numbers in parentheses are patients at risk at that time interval.
ry c January 2010
FIGURE 2. Freedom from any reoperation, reoperation on the pulmonary
autograft, and reoperation or catheter-based pulmonary valve implantation.
FIGURE 3. Freedom from moderate or severe (3þ) and greater than mild
(>2þ) aortic insufficiency.
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with prolapse. Three valves had cusp tears in the commis-
sural areas. Microscopic analysis revealed fragmentation
of the fibrous and elastic tissues and distortion of the normal
histology. The basal region showed thickening caused by
pannus.AI
The most recently performed echocardiographic study
before reoperation or death showed trace or no AI in 129
(61%) patients, mild AI in 54 (25.6%) patients, mild-to-
moderate AI in 15 (7.1%) patients, moderate AI in 8
(3.8%) patients, and severe AI in 5 (2.4%) patients. Figure 3
shows the freedom from moderate and severe AI (13
patients), as well as greater than mild AI (28 patients), based
on 199 echocardiograms reviewed by us. Table 2 shows
freedom from greater than mild AI in various subgroups of
patients. Results were truncated at 14 years because of
sample size. The cutoff for annulus size of less than 27
mm and 27 mm or larger was based on the mean aortic
annulus diameter for all patients. Cox regression analysis
identified male sex (HR, 8.8; 95% CI, 2.1–33.7; P ¼
.003) as the only predictor of postoperative AI.Dilation of the Pulmonary Autograft
Dilation of the pulmonary autograft, which was defined as
diameter of the neoaortic root sinuses of greater than 39 mm,
occurred in 31 (15.5%) of 199 studied patients. Congenital
aortic valve disease was present in 26 of 31 patients, annular
mismatch was present in 25 of 31 patients, preoperative AI
was present in 16 of 31 patients, and aortic root replacement
was present in 25 of 31 patients. Cox regression analysis
disclosed preoperative AI (HR, 2.8; 95% CI, 1.2–6.5; P ¼
.014) and aortic root replacement (HR, 5.9; 95% CI, 2.0–
16.7; P ¼ .001) as independent predictors of dilation of
the pulmonary autograft sinuses. Only 7 (3.5%) patientsThe Journal of Thoracic and Chad a neoaortic root larger than 45 mm, and only 1 has
required replacement of the ascending aorta (>50 mm).Pulmonary Homograft
Freedom from pulmonary valve insufficiency of moderate
or severe degree, a peak systolic gradient of 40 mm Hg or
greater, or both at 5, 10, and 15 years was 100%, 95.1%
 1.8%, and 70.8%  6.8%, respectively.Late Functional Class and Event-Free Survival
At the latest follow-up contact, 180 (92%) patients were
in functional class I, 12 (6%) were in class II, and 4 (2%)
were in class III. The event-free survival at 15 years was
81%  3.7%.DISCUSSION
The Ross operation is a complex procedure, and the
operative mortality associated with it is quite variable among
reports. In a recently published meta-analysis on outcomes
of the Ross operation by Takkenberg and colleagues,8 the
operative mortality in adult patients was 3.24%, ranging
from 0.3% to 6.8% among 12 studies. We believe that the
mortality rate for aortic valve replacement in young adults
should be 1% or less.9 In our series of patients undergoing
the Ross operation, the operative mortality was 0.47%,
and the long-term survival was similar to that of the general
population. Other reports on this operation in young
adults showed survival similar to that of the general
population.7-12 However, this finding is not consistent in
all studies on longitudinal outcomes of the Ross operation.8
One would expect a favorable long-term survival in compar-
ison with other valves because of the pulmonary autograft’s
hemodynamic and biologic features,13 but given its technical
complexity and the fact that single-valve disease is treated
with an operation that involves replacement of 2 valves,ardiovascular Surgery c Volume 139, Number 1 71
TABLE 3. Freedom from aortic insufficiency greater than mild (28 patients)
5 y 10 y 14 y P value
Operative technique
Subcoronary/inclusion 97.0  1.6 (80) 81.9  5.2 (44) 75.5  6.5 (12)
Root replacement 97.6  1.6 (94) 91.7  3.2 (43) 73.6  8.1 (11) .599
Aortic/pulmonary annulus
No mismatch 100 (95) 93.0  3.4 (45) 90.6  4.0 (11)
Mismatch 94.2  2.5 (79) 82.5  4.7 (42) 61.9  8.3 (12) .001
Aortic annulus diameter
<27 mm 100 (77) 93.2  3.7 (36) 86.0  7.2 (9)
27 mm 95.3  2.0 (97) 83.9  3.9 (51) 66.9  6.5 (14) .007
Aortic valve lesion
Stenosis 100 (89) 93.1  3.3 (44) 87.3  6.4 (8)
Insufficiency 92.8  3.1 (61) 80.7  5.7 (29) 64.8  8.6 (11)
Mixed 100 (24) 84.3  8.3 (14) 64.4  14.5 (4) .022
Sex
Female 100 (63) 95.5  3.1 (36) 89.1  6.8 (9)
Male 95.9  1.7 (111) 82.9  4.2 (51) 65.8  7.3 (14) .001
All values are shown in percentages. P values were determined by using the log-rank test. Numbers in parentheses are patients at risk at that time interval.
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seen with other types of heart valve substitutes.
Early on in our experience with the Ross operation, we
observed that the pulmonary and aortic roots often had
different dimensions, and we had to reduce the diameter of
the aortic annulus to match the smaller pulmonary annulus.6
This maneuver certainly prevented early postoperative AI,
but as it turned out, mismatch in sizes between the aortic
and pulmonary annuli was associated with an increased
risk of late pulmonary autograft failure, as defined by the de-
velopment of greater than mild AI. A dilated aortic annulus
was commonly associated with incompetent congenital
aortic valve disease, but it was also found in some patients
with aortic stenosis and mixed lesions. Actually, the mean
diameter of the aortic annulus in our patients was higher
than normal when compared with values derived from mea-
surement of aortic valve homografts by CryoLife, Inc (G.
Kennesaw).14 There were no reoperations on the pulmonary
autograft in patients with an aortic annulus of less than 27
mm, and the incidence of greater than mild AI was much
lower in patients with a smaller aortic annulus. A dilated aor-
tic annulus is probably a marker of connective tissue disor-
der, which might predict premature degeneration of the
pulmonary autograft cusps. Indeed, in this study degenera-
tion of the pulmonary autograft cusps was present in 9 of
10 patients who had reoperations on the pulmonary auto-
graft, all of whom had a dilated aortic annulus (27 mm).
Annular mismatch, an aortic annulus of 27 mm or larger,
preoperative AI, and male sex were associated with higher
probability of reoperation on the autograft and late postoper-
ative AI by means of log-rank analysis, as shown in Tables 2
and 3. Cox regression analyses revealed that preoperative AI
was the only independent predictor of reoperation on the
pulmonary autograft, whereas male sex was the only72 The Journal of Thoracic and Cardiovascular Surgepredictor of greater than mild AI. The technique of implan-
tation of the pulmonary autograft had no effect on freedom
from reoperation or on the development of late AI.
The best outcomes in our series were in patients with
a normal aortic annulus smaller than 27 mm in diameter
and in women.
Elkins and associates10 reported on their 16-year results
with the Ross operation in 487 patients, including 197 aged
18 years and less. The technique of aortic root replacement
was used in 80% of their patients. The long-term survival
paralleled but was lower than that of the general population
matched for age, sex, and year of operation. Those investiga-
tors defined pulmonary autograft failure as the need for reop-
eration or valve-related death, and the freedom at 16 years
was 74% 5%. Male sex and AI were identified as indepen-
dent predictors of pulmonary autograft failure.
Bo¨hm and coworkers15 from Germany recently reported
another large series of Ross operations. They operated on
467 patients with a mean age of 42 years and used almost
exclusively the technique of aortic root replacement. After
a mean follow-up of 5.5 years, only 18 patients had reoper-
ations on the pulmonary autograft, and the freedom from
reoperation or AI greater than mild at 10 years was 94.2%
 2.8%. They found that pulmonary autograft regurgitation
was 6 times more common in men than in women but made
no inferences about valve lesion or aortic annulus size.
In previous publications we expressed concern about
dilation of the pulmonary autograft when implanted as
a freestanding aortic root and suggested that the modified
subcoronary or aortic root inclusion technique might pre-
vent dilation.6 Although the pulmonary autograft dilates
after being transferred to the systemic circulation, the pres-
ent study indicates that the degree of dilation became
a problem only in a small proportion of patients andry c January 2010
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replacement and had preoperative AI caused by congenital
aortic valve disease. Thus it is possible that the operative
technique plays a role on late dilation and eventual failure
of the pulmonary autograft, but our sample size was rela-
tively small to demonstrate that.
In addition to the complexity of the Ross operation, another
common criticism is that it requires a pulmonary homograft,
which can also fail. Failure of the pulmonary homograft is
a problem in young children but less so in young adults and
older patients.16-18 Actually, the pulmonary homograft in
young children seems to be more durable after the Ross oper-
ation than after other types of right ventricular outflow tract
reconstruction for congenital heart disease.18 In our series
only 3 patients have required reintervention for a freedom
from reoperation of 97.3%  1.6%, but the freedom from
pulmonary dysfunction, as defined as moderate or severe
pulmonary insufficiency, a peak systolic gradient of 40 mm
Hg or greater, or both at 15 years, was 70.8%  6.8%. The
fate of the pulmonary homograft after the Ross operation
varies among reports depending on how dysfunction is
defined, but it is not a serious problem.10-12 In addition,
with the advent of catheter-based pulmonary valve implanta-
tion, this problem is further mitigated.
In spite of all the valve-related problems described in the
study, 185 (87%) of 212 patients were free from any cardio-
vascular complications after a mean follow-up of 10 years. If
patients with a dilated aortic annulus were excluded, the
results were indeed excellent and probably compare favor-
ably with those of other types of heart valve substitutes for
aortic valve replacement in young adults.18-20
In summary, this study showed excellent long-term out-
comes after the Ross operation in female patients and in
other patients with an aortic annulus less than 27 mm in di-
ameter. Patients with aortic stenosis are more likely to do
well than those with AI. The technique of implantation
had no demonstrable effect on the fate of the operation,
but patients with a dilated aortic annulus did not fare well,
and reduction of the aortic annulus at the time of surgical
intervention did not resolve the problem, suggesting that
a dilated aortic annulus might be a marker for premature
degeneration of the pulmonary autograft cusps.References
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Dr Lawrence Cohn (Boston, Mass). Tirone, as usual, an excel-
lent paper with superb results. I have no conflicts to present. I think
especially notable is the superb survival, as it should be in this very
young group of adults. I think the real message is that proper pa-
tients should have excellent and good early and late survival; the
gender observation is obviously quite new.
The message I got from your paper is that you should not do
a Ross operation if you have severe aortic regurgitation with a bi-
cuspid aortic valve or when the aortic annulus is quite a bit bigger
than the pulmonary valve annulus. That seems very, very clear.
You did annular and sinotubular banding procedures. I am con-
cluding that they were not effective. Is that fair to say?
Dr David. That’s correct. I do believe that a dilated aortic annu-
lus is a marker of premature degenerative disease of a pulmonary
valve; work that we have been doing for 20 years now.
Dr Cohn. Agreed. Would it be fair then to say that aortic regur-
gitation in a bicuspid aortic valve is a contraindication to the Ross
operation?ardiovascular Surgery c Volume 139, Number 1 73
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because surgical adjustment of the dilated annulus did not prevent
the pulmonary cusps to degenerate prematurely.
Dr Cohn. Your reoperation rate for the pulmonary autograft was
very, very good. I found it fascinating that you did equally a number
of subcoronary procedures, as the original Ross procedure was con-
ceived, as opposed to the root. Are these intermingled? How do you
choose to do one or the other, or were these sequential? In all the
ones that we did, a much smaller series to be sure, but the only
ones I did were all root replacement.
Dr David. Our experience with aortic valve homograft preceded
the pulmonary autograft. I started doing aortic homografts when I
started practicing, and always opened the aortic root down to the
aortic annulus to increase exposure of the right and left aortic si-
nuses. If the relationship between the coronary artery orifices and
annulus was fairly normal, that is, the coronary artery was in the
center of the sinus, we scalloped the left and the right, did subcoro-
nary for the left and right, left the noncoronary sinus of the donor
valve was left intact, and did the upper anastomosis, closed the aor-
tic root at the end of the operation only if there was enough tissue. If
there was enough, we used a patch of autologous pericardium. So
there was a reason to do one or the other procedure. If the anatomy
was not normal, if the coronaries were at 180 degrees, it was diffi-
cult to align a tricuspid valve into it and those patients had root re-
placement. And that is the bias perhaps that cannot be measured. It
was an intraoperative decision to do one or the other procedure.
Dr Cohn. My last question relates to the reconstruction of the
pulmonary homograft. In our smaller series we found several pa-
tients that ended up with pulmonary trunk hyperplasia, endothelial
hyperplasia. Have you seen this in any of the patients, because you
had a moderate number that had pulmonary insufficiency and/or
pulmonary gradients greater than 40? As you said, you readjusted
those numbers from the abstract. Have you seen this and how do
you treat these people and when do you feel it is time to intervene
when you have this sort of progressive pulmonary stenosis or pul-
monary regurgitation?
Dr David. Every patient who had a mean systolic gradient by
echo more than 40 was a potential candidate to have pulmonary
valve intervention. Those patients underwent heart catheteriza-
tion, and it was amazing how often the echo gradients were in-
correct and at catheterization we found only mean gradients of
10 to 20 and, because the patients had no right ventricular hyper-
trophy of dysfunction, we left them alone. The stenosis almost
invariably is at the pulmonary artery level, not at the cusps.
The cusps remain pretty normal and the pulmonary artery of
the donor becomes stenotic. If it is possible that is caused by in-
flammatory reaction. Since it could be due inflammation, we
treated these patients with a high dose of aspirin, but aspirin is
the only thing we give. I don’t know if that inflammatory reaction
can be prevented. With advent of percutaneous valve deploy-
ment, managing pulmonary homograft dysfunction should
become less of problematic in the future.
Dr Cohn. Super paper.
Dr David. Thank you.
Dr Peter Skillington (Melbourne, Australia). Thank you very
much, Tirone. It was a very good paper. I just wonder what your
current approach is now then for a patient with coronary arteries ab-
normally positioned? Is it a subcoronary?74 The Journal of Thoracic and Cardiovascular SurgeDr David. Scalloped on the left and right, and then we leave the
noncoronary sinus of the pulmonary autograft intact, do a distal
anastomosis, unclamp, and then after you do the echo, if there is
enough tissue, close the root primarily around the modified sub-
coronary. If there is not enough tissue, we put a patch of pericar-
dium there to close.
Our intention was to prove that root replacement was bad. Our
data doesn’t support that.
Dr Skillington. You are not the first one to note that female pa-
tients seem to do better. Can you speculate as to the reasons for
that?
Dr David. I initially thought because most of them have aortic
stenosis as opposed to insufficiency. I don’t know enough about
the multivariable analysis but our biostatistician reran 3 or 4 times
different models, and women always emerged as a predictor of bet-
ter outcome. I don’t know the answer. As you said, we are not the
first ones to point this out. Ronald Elkins with a much larger series
showed that female was a protecting effect as well, and Dr Elkins
had done mostly root replacement.
Dr Skillington. My final question, what do you think the really
long-term fate of the pulmonary allograft valve is going to be?
Dr David. I think it is like the aortic homograft and is going to
fail, unfortunately. However, if at 20 years half of them are still
functioning well and they can deploy a percutaneous valve that
might last another 15, 20 years, it is not that big a deal. Obviously,
we had to adapt your practice to our environment. Where I practice,
anticoagulation on a 25-year-old is a major problem. It is not a mi-
nor thing for either young men or women to have a mechanical
valve and take Coumadin. So we continue seeking for a better bi-
ological valve. I don’t think the Ross is a bad option, and I have
to tell you that, since we discovered this last year, we have done an-
other 20 patients. We are doing a Ross routinely again for anyone
with aortic stenosis who does not wish to take anticoagulants. And,
of course, one has to be relatively young. It doesn’t make any sense
to do it in a 70-year-old, but in a 50-year-old or younger, why not?
Dr A. Sampath Kumar (New Delhi, India). Dr David, I must
congratulate you on a wonderful experience and a good presentation
on this large series. We started doing Ross procedures in 1993, and
from the very first case we did only root replacements. We never did
a scalloped subcoronary. And we did not do a Ross procedure if the
aortic root annulus measured more than 30 mm. I think your obser-
vation is very correct and I agree with you that if there is aortic root
dilatation, we believe 30 mm is the limit. Beyond that, the Ross pro-
cedure is going to fail. The other observation we made in rheumatics
is that the pulmonary valve is already subjected to high pressure be-
cause of the pulmonary hypertension and is a much better autograft
to use as a replacement for the aortic valve.
Thank you very much for giving me this opportunity to com-
ment.
Dr David. A retrospective review from the tissue bank in Europe
supports what you are saying. There was a time in the early 1990s
that we would use a pulmonary homograft to replace the aortic
valve, and early failures were common. At five years, more than
half of them failed. At 10 years, approximately 1 in 3 was still func-
tioning as well as aortic valve homograft. They went back to the do-
nors, and the valves of donors with pulmonary hypertension did as
well as aortic homograft. They probably had had heart-lung trans-
plant, and the pulmonary valves of those donors tolerated systemicry c January 2010
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adapt to high pressure. So the rheumatic who has pulmonary hyper-
tension is likely to do better because the pulmonary valve is indeed
already prepared to sustain systemic pressure.
Dr Kumar. There are several advantages with pulmonary hyper-
tension. First, the autograft is easier to take out because the muscle
is quite thick and you are not likely to injure the first septal artery.
The pulmonary artery wall is pretty thick, so it is very good; it has
already adapted to the high pressures in the aortic position. So I
think it is a good advantage to do it in patients with pulmonary
hypertension. Thank you.
Dr John Fehrenbacher (Indianapolis, Ind). I do have a disclo-
sure with CryoLife. I am a consultant.
Dr David, remarkable results. I don’t know in the literature that
any other mechanical or tissue valve has almost a 97% 15-year sur-
vival, but maybe in your hands, mechanical or tissue valves do.
Knowing these results, why not use the Ross in somebody who
has aortic insufficiency when it provides such excellent 15-year
survival versus putting in a mechanical or a tissue valve that may
not have these excellent results?
Dr David. Well, what I didn’t say was that all patients who had
reoperations did not die. So the most serious valve-related compli-
cation in this series, which was valve failure, was not a cause of
death and this may have contributed to a late survival similar toThe Journal of Thoracic and Cthat of a matched general population. Thus, if no patient died
from a valve-related complication, one should expect death only
by the same causes and in the population in general.
The problems of aortic insufficiency are more complicated. In
20-year-old patients who have a 30%-40% chance to have aortic
insufficiency at 15 years, I am not so sure the Ross is much better
than a tissue valve, particularly the newer tissue valves. So the
Ross procedure should give the patient results better than existing
bioprosthetic valves. Bioprosthetic valves are not bad anymore.
Some of them are actually very good. We have experience
with 2 of them: Carpentier-Edwards Perimount and Hancock II.
We practically have no reoperation for valve failure during the
first decade. In the second decade they come back but I think
it parallels the failures of the Ross for aortic insufficiency, but
not for aortic stenosis. So I think the Ross is an ideal procedure
for a stenotic aortic valve. It is less than perfect for aortic
insufficiency.
My main concern is that aortic insufficiency in congenital aortic
valve disease may be a marker for premature degenerative process
in a pulmonary valve. We published a study suggesting that bicus-
pid aortic valve was the bad fellow. I think we were wrong. It was
not bicuspid aortic valve; it was the bicuspid aortic valve with di-
lated aortic annulus that was bad. This does not apply to rheumatic
aortic insufficiency, as Professor Kumar mentioned.ardiovascular Surgery c Volume 139, Number 1 75
